Blast Transformation of Chronic Myeloid Leukemia Driven by Acquisition of t(8;21)(q22;q22)/RUNX1::RUNX1T1: Selecting Optimal Treatment Based on Clinical and Molecular Findings. This evidence concerns the gene RUNX1T1 and chronic myelogenous leukemia, BCR-ABL1 positive.